Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ATB Therapeutics Logo
ATB Therapeutics Growth Score
90
CB Rank
13890
Heat Score
68
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
Founded
obfuscation
PrivateSeries A Aye, Luxembourg, Belgium11-50 atbtherapeutics.com
Biotechnology
Health Care
Therapeutics
Overview

ATB Therapeutics
Total Funding
obfuscation
Growth Score
90
Heat Score
68

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score90
-2 pts
in past quarter
Heat Score 68
13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About ATB Therapeutics

CB Rank
13890
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
Founded
obfuscation
PrivateSeries A Aye, Luxembourg, Belgium11-50 atbtherapeutics.com
Biotechnology
Health Care
Therapeutics

Funding Rounds

Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name ATB Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Phone Number +32 472 22 74 01
Contact Email info@atbtherapeutics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

atbody
Bifunctional antibodies designed to treat hematological malignancies, solid tumors, and autoimmune diseases by combining multiple targeting and killing domains.
atbiofarm
A plant-based manufacturing technology for producing stable and homogenous biologics, facilitating the creation of the atbody format.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A
obfuscation
Series A - ATB Therapeutics Logo
Series A - ATB Therapeutics
7
obfuscation
EQT Life Sciences, MRL Ventures FundSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 5 Board Members and Advisors 7 Contacts 3

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

661
87.25%
 in past month

IT Spend

$65.1KThis year, ATB Therapeutics is projected to spend $65.1K on IT, according to Aberdeen.

Active Website Tech Count

23ATB Therapeutics is actively using 23 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Euro.

Total IP

6The intellectual property of ATB Therapeutics includes 5 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, ATB Therapeutics has 1 registered trademark in the 'Chemical substances' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ATB Therapeutics's headquarters? ATB Therapeutics is located in Aye, Luxembourg, Belgium.Who invested in ATB Therapeutics? ATB Therapeutics has 11 investors including EQT Life Sciences and  V-Bio Ventures.When was the last funding round for ATB Therapeutics? ATB Therapeutics closed its last funding round on
obfuscation
from a Series A round.Who are ATB Therapeutics's competitors? Alternatives and possible competitors to ATB Therapeutics may include Regeneron, Amgen, and  Anaveon.How much funding has ATB Therapeutics raised to date? ATB Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|